Dec 03, 2020
Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab) is Safe and Well Tolerated in Phase IIa HBV Study
Nov 29, 2020
Gannex Appoints Former Takeda Head of Liver Disease Clinical Development Melissa Palmer, MD as Chief Medical Officer
Nov 18, 2020
ASC40 (TVB-2640) Phase 2 NASH Trial Completed Patient Enrollment in China
Nov 18, 2020
Change in Use of Proceeds From the Global Offering for Expansion of R&D Portfolio into Hepatitis B Clinical Cure and NASH
Oct 11, 2020
Gannex Received U.S. IND Approval for Its NASH Drug Candidate ASC42 an FXR Agonist
Sep 13, 2020
Gannex Filed US IND for Its NASH Drug ASC42, an FXR Agonist
Sep 09, 2020
Gannex and Galmed Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist)
Aug 20, 2020
Ascletis Completed Bridging Study of ASC18, a One-pill, Once-a-day Complete HCV Oral Regimen
Jul 30, 2020
Ascletis' All-oral HCV Treatment Approved for Marketing in China
Jul 19, 2020
Bridging Study in China Completed for NASH Drug Candidate ASC40
Jun 17, 2020
ASC40 (TVB-2640) Significantly Reduced Liver Fat With a 61% Responder Rate in Phase 2 NASH Trial
May 13, 2020
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication
Apr 13, 2020
Ascletis Receives IND Approval for its HIV Drug ASC09F
Mar 31, 2020
Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020
Mar 24, 2020
Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patients
Mar 10, 2020
Progress of the Small Sample Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
Feb 26, 2020
Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
Feb 17, 2020
Ascletis' IND Filing for Its Non-alcoholic Steatohepatitis (NASH) Drug Accepted by NMPA
Jan 22, 2020
Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody
Nov 28, 2019
Ascletis successfully obtained Pharmaceutical Trade License and GSP Certificate, formed a Complete Commercial Layout